Skip Navigation

Find a Doctor

Find a Researcher


Chen Hu, M.S., Ph.D.

Photo of Dr. Chen Hu, M.S., Ph.D.
  • Assistant Professor of Oncology

Research Interests

oncology clinical trial design, conduct and analysis; statistical methods for longitudinal and survival outcomes in clinical oncology studies; alternative endpoint evaluation; benefit-risk assessment; missing data analysis. more



  • Assistant Professor of Oncology

Departments / Divisions

Centers & Institutes



  • Ph.D., University of Michigan (Ann Arbor) (Michigan) (2012)
  • M.S., University of Michigan (Ann Arbor) (Michigan) (2007)

Research & Publications

Selected Publications

Hu C, Tsodikov A. Semiparametric regression analysis for time-to-event marked endpoints in cancer studies. Biostatistics, 2014; 15(3) 513-525.

Hu C, Tsodikov A. Joint modeling approach for semicompeting risks data with missing nonterminal event status. Lifetime Data Anal. 2014; 20(4)563-583.

Prabhu RS, Won M, Shaw, EG, Hu C, Brachman, DG, Buckner, JC, Stelzer, KJ, Barger, GR Brown, PD, Gilbert MR, Mehta M P. Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. J Clin Oncol, 2014; 32(6)535-541.

Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W, Choy, H. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015; 16(2):187-199.

Movsas B, Hu C, Sloan J, Bradley JD, Komaki R, Master G, Kavadi VS, Narayan S, Michalski JM, Johnson DW, Koprowski C., Curran WJ, Graces YI, Gaur R, Wynn RB, Schallenkamp J, Gelblum DY, MacRae RM, Paulus R, Choy H. Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol, Published online November 25, 2015. doi:10.1001/jamaoncol.2015.3969.

Is this you? Edit Profile
back to top button